Brief: Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program At IWGGD Symposium
11/05/2022 14:31
May 11 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS PRESENTS POSITIVE PRECLINICAL DATA ON
ITS
GAUCHER DISEASE PROGRAM AT IWGGD SYMPOSIUM
Source text for Eikon: ID:nGNXMJlRx
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall